Compared to Treatment A (OROS® hydromorphone 16 mg; fasting conditions)  what was the result of Treatment B (OROS® hydromorphone 16 mg; fed conditions on Median time to peak plasma concentration (Tmax)?
Median Tmax was achieved 4 hours earlier when OROS® hydromorphone was administered under fed conditions compared with fasting conditions (12 vs. 16 hours; P = 0.0062).